Stocks and Investing
Stocks and Investing
Thu, June 13, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tessa Romero Initiated (AGIO) at Hold and Held Target at $46 on, Jun 13th, 2024
Tessa Romero of JP Morgan, Initiated "Agios Pharmaceuticals, Inc." (AGIO) at Hold and Held Target at $46 on, Jun 13th, 2024.
Tessa has made no other calls on AGIO in the last 4 months.
There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 1 agrees with Tessa's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $53 on, Tuesday, June 4th, 2024
These are the ratings of the 2 analyists that currently disagree with Tessa
- Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $53 on, Tuesday, June 4th, 2024
- Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy on, Tuesday, April 9th, 2024
Contributing Sources